← All trials
NCT00664859
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2007
- Primary completion
- Feb 1, 2009
- Completion date
- Feb 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 220
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Veloxis PharmaceuticalsLead sponsor
- Radiant ResearchOverall official - principal investigator
- Radiant ResearchStudy director
- Coastal Carolina ResearchStudy director
- Diabetes and Glandular Disease Research Associates Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.